These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice. Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422 [TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Jin H; Kanthasamy A; Ghosh A; Anantharam V; Kalyanaraman B; Kanthasamy AG Biochim Biophys Acta; 2014 Aug; 1842(8):1282-94. PubMed ID: 24060637 [TBL] [Abstract][Full Text] [Related]
4. Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson's disease. Jahromi SR; Haddadi M; Shivanandappa T; Ramesh SR Neuroscience; 2015 May; 293():136-50. PubMed ID: 25754960 [TBL] [Abstract][Full Text] [Related]
5. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109 [TBL] [Abstract][Full Text] [Related]
6. Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease. Behl T; Kaur G; Sehgal A; Zengin G; Singh S; Ahmadi A; Bungau S Curr Neuropharmacol; 2022; 20(2):324-343. PubMed ID: 34030619 [TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation. Percário S; da Silva Barbosa A; Varela ELP; Gomes ARQ; Ferreira MES; de Nazaré Araújo Moreira T; Dolabela MF Oxid Med Cell Longev; 2020; 2020():2360872. PubMed ID: 33101584 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and neuroinflammation in the story of Parkinson's disease: Could targeting these pathways write a good ending? Hassanzadeh K; Rahimmi A J Cell Physiol; 2018 Jan; 234(1):23-32. PubMed ID: 30078201 [TBL] [Abstract][Full Text] [Related]
10. Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models. Choi JG; Kim HG; Kim MC; Yang WM; Huh Y; Kim SY; Oh MS J Ethnopharmacol; 2011 Mar; 134(2):414-21. PubMed ID: 21195155 [TBL] [Abstract][Full Text] [Related]
11. Effects of pharmacological agents on the lifespan phenotype of Drosophila DJ-1beta mutants. Lavara-Culebras E; Muñoz-Soriano V; Gómez-Pastor R; Matallana E; Paricio N Gene; 2010 Aug; 462(1-2):26-33. PubMed ID: 20423725 [TBL] [Abstract][Full Text] [Related]
12. Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease. Sanz E; Romera M; Bellik L; Marco JI; Unzeta M Med Sci Monit; 2004 Dec; 10(12):BR477-84. PubMed ID: 15567979 [TBL] [Abstract][Full Text] [Related]
13. Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease. Kim S; Park SE; Sapkota K; Kim MK; Kim SJ J Pharm Pharmacol; 2011 Oct; 63(10):1358-67. PubMed ID: 21899552 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease. Azam F; Barodia SK; Anwer T; Alam MM J Enzyme Inhib Med Chem; 2009 Jun; 24(3):808-17. PubMed ID: 18846462 [TBL] [Abstract][Full Text] [Related]
15. [Reactive oxygen species and 3,4-dihydroxyphenylacetaldehyde in pathogenesis of Parkinson disease]. Rybakowska I; Szreder G; Kaletha K; Barwina M; Waldman W; Sein Anand J Przegl Lek; 2011; 68(8):486-7. PubMed ID: 22010445 [TBL] [Abstract][Full Text] [Related]
16. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease. Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534 [TBL] [Abstract][Full Text] [Related]
17. Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: Implications for Parkinson's disease. Harish G; Venkateshappa C; Mythri RB; Dubey SK; Mishra K; Singh N; Vali S; Bharath MM Bioorg Med Chem; 2010 Apr; 18(7):2631-8. PubMed ID: 20227282 [TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease. Witt SN; Flower TR FEMS Yeast Res; 2006 Dec; 6(8):1107-16. PubMed ID: 17156009 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease. Thakur P; Nehru B Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314 [TBL] [Abstract][Full Text] [Related]
20. Can we prevent Parkinson's and Alzheimer's disease? Kedar NP J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]